4.7 Article

Subcellular-Targeted Near-Infrared-Responsive Nanomedicine with Synergistic Chemo-photothermal Therapy against Multidrug Resistant Cancer

Journal

MOLECULAR PHARMACEUTICS
Volume 19, Issue 12, Pages 4538-4551

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.1c00998

Keywords

multidrug resistance; mitochondrial targeting; chemo-photothermal therapy; synergistic effect; near-infrared irradiation

Funding

  1. National Natural Science Foundation of China [51803174]
  2. Sichuan Science and Technology Program [2020YFH0151]

Ask authors/readers for more resources

Multidrug resistance is a significant challenge in cancer treatment, and combining chemotherapy with photothermal therapy has shown potential in overcoming MDR. In this study, a subcellular-targeted near-infrared-responsive nanomedicine was developed, which achieved improved photothermal stability and efficiency. This nanomedicine could enhance MDR cancer treatment by combining chemotherapy and photothermal therapy.
ABSTRACT: Multidrug resistance (MDR) is a major obstacle to effective cancer treatment. Therefore, developing effective approaches for overcoming the limitation of MDR in cancer therapy is very essential. Chemotherapy combined with photothermal therapy (PTT) is a potential therapeutic option against MDR. Herein, we developed a subcellular-targeted near-infrared (NIR)-responsive nanomedicine (Fe3O4@PDA-TPP/S2-PEG-hyd-DOX, abbreviated as Fe3O4-ATSPD) as a new photothermal agent with improved photothermal stability and efficiency. This system demonstrates high stability in blood circulation and can be accumulated at the tumor site by magnetic targeting enhanced permeability and retention effect (EPR). Near-infrared (NIR) irradiation at the tumor site generates a photothermal effect from the photosensitizer Fe3O4@PDA, leading to a dramatic decrease in mitochondrial membrane potential. Simultaneously, the conjugated drugs released under low pH condition in endosomes or lysosomes cause nucleus DNA damage and cell apoptosis. This subcellulartargeted NIR-responsive nanomedicine with efficient integration of diagnosis and therapy could significantly enhance MDR cancer treatment by combination of chemotherapy and PTT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available